Prentice Wealth Management LLC Acadia Pharmaceuticals Inc Transaction History

Prentice Wealth Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 28, 2022	SELL	$13.01 - $27.22 $2,953 - $6,178	-227 Closed	0 $0
Q2 2021 Aug 11, 2021	SELL	$19.4 - $27.42 $194 - $274	-10 Reduced 4.22%	227 $6,000
Q1 2021 Jun 17, 2021	SELL	$25.02 - $54.99 $147,067 - $323,231	-5,878 Reduced 96.12%	237 $6,000
Q1 2021 Jun 08, 2021	BUY	$25.02 - $54.99 $152,997 - $336,263	6,115 New	6,115 $6,000

281

156M

901K

314K

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.79B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

Get notified when there are updates to the investment portfolio of Prentice Wealth Management LLC, based on Form 13F filings with the SEC.

Stay updated on Prentice Wealth Management LLC with notifications on news.